IRMD - Iradimed Co - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IRMD is currently covered by 1 analysts with an average price target of $89.43. This is a potential upside of $16.77 (23.08%) from yesterday's end of day stock price of $72.66.

Iradimed Co's activity chart (see below) currently has 0 price targets and 3 ratings on display. The stock rating distribution of IRMD is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 273 days.

Highest price target for IRMD is $72, Lowest price target is $72, average price target is $72.

Most recent stock forecast was given by JASON WITTES from ROTH MKM on 14-Feb-2025. First documented stock forecast 22-Apr-2024.

Best performing analysts who are covering IRMD - Iradimed Co:

Jason Wittes

Currently out of the existing stock ratings of IRMD, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$72

$-0.66 (-0.91%)

$60

6 months 9 days ago
(14-Feb-2025)

3/3 (100%)

$16.77 (30.36%)

273

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IRMD (Iradimed Co) average time for price targets to be met?

On average it took 273 days on average for the stock forecasts to be realized with a an average price target met ratio 100

Which analyst has the current highest performing score on IRMD (Iradimed Co) with a proven track record?

JASON WITTES

Which analyst has the most public recommendations on IRMD (Iradimed Co)?

Jason Wittes has 9 price targets and 8 ratings on IRMD

Which analyst is the currently most bullish on IRMD (Iradimed Co)?

Jason Wittes with highest potential upside - $-0.66

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?